News | NML

Recent News

Nanomerics announces ocular progress with new patents and two key publications

May 23

Nanomerics announces ocular progress with new patents and two key publications

Nanomerics Ltd., a world leader in molecular engineered delivery technologies, today announced the Company had been granted patent...

Nanomerics CSO Prof IF Uchegbu elected to Academy of Medical Sciences

May 12

Nanomerics CSO Prof IF Uchegbu elected to Academy of Medical Sciences

Today the UK Academy of Medical Sciences announced the election of 50 new biomedical health scientists to its influential fellowship;...

Double Milestone Payment Strengthens Nanomerics' Balance Sheet and Enables Clinical Programs

Mar 23

Double Milestone Payment Strengthens Nanomerics' Balance Sheet and Enables Clinical Programs

Nanomerics Ltd., a world leader in molecular engineered delivery technologies, today announced that the Company had received its first...

Nanomerics Molecular Mask MM019 inhibits SARS-CoV-2 replication

Dec 12, 2020

Nanomerics Molecular Mask MM019 inhibits SARS-CoV-2 replication

Nanomerics Molecular Mask MM019 inhibits SARS-CoV-2 replication in ex-vivo human airway epithelial air liquid interface cultures. Today...

Nanomerics receives pIND guidance from the US FDA for NM134

Aug 3, 2020

Nanomerics receives pIND guidance from the US FDA for NM134

Today Nanomerics received supportive pIND guidance from the US FDA on the development of its asset - NM134. NM134 is indicated for the...